fda glp-1 compounding warning letters september 2025 U.S. sends drug advertising to Lilly, Novo, Hims August 11, 2025: The FDA

Patients should: Stay well hydrated Eat smaller, more frequent meals Avoid high-fat, greasy, or very spicy foods if experiencing nausea Report persistent or severe symptoms to their prescriber When to seek medical advice: Contact your GP or diabetes team for: Persistent vomiting or diarrhoea Concerns about medication effects or side effects Symptoms of hypoglycaemia if taking other diabetes medications Contact NHS 111 or seek urgent care for: Severe, persistent vomiting preventing fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Severe or persistent abdominal pain, particularly if radiating to the back (potential pancreatitis) Pain in the right upper abdomen, yellowing of skin/eyes (potential gallbladder issues) Sudden vision changes Allergic reactions (rash, difficulty breathing, facial swelling) Most patients find that side effects diminish significantly after 812 weeks, and the benefits of appetite control and metabolic improvement become more apparent

Through Josie, licensed providers may prescribe compounded GLP-1 medications, including semaglutide and tirzepatide, available as a weekly injection or a dissolvable tablet

The studies are correlative, but appear to show that the drugs not only reverse the carcinogenic risks that come with obesity, they may also have additional anti-inflammatory effects that help suppress tumors

Our journey began with a shared vision to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions